Patents by Inventor Anne M. ROBINSON

Anne M. ROBINSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating crohn's disease and ulcerative colitis
    Patent number: 11564922
    Abstract: The present disclosure is directed to methods for treating Crohn's disease, and in particular, to methods for inducing clinical remission and/or endoscopic improvement of Crohn's disease, using a JAK1 inhibitor. In certain embodiments, the patient is administered an induction dose of the JAK1 inhibitor to induce clinical remission and/or endoscopic improvement of the Crohn's disease, followed by administration of at least one maintenance dose of the JAK1 inhibitor thereafter. In other embodiments, the present disclosure is directed to methods for treating ulcerative colitis using a JAK1 inhibitor.
    Type: Grant
    Filed: April 28, 2022
    Date of Patent: January 31, 2023
    Assignee: AbbVie Inc.
    Inventors: Aileen L. Pangan, Roopal B. Thakkar, Steven Jungerwirth, Ana Paula Machado De Lacerda, Anne M. Robinson, Mohamed-Eslam F. Mohamed, Ahmed A. Othman, Ben Klünder, Wen Zhou
  • METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS
    Publication number: 20220273651
    Abstract: The present disclosure is directed to methods for treating Crohn's disease, and in particular, to methods for inducing clinical remission and/or endoscopic improvement of Crohn's disease, using a JAK1 inhibitor. In certain embodiments, the patient is administered an induction dose of the JAK1 inhibitor to induce clinical remission and/or endoscopic improvement of the Crohn's disease, followed by administration of at least one maintenance dose of the JAK1 inhibitor thereafter. In other embodiments, the present disclosure is directed to methods for treating ulcerative colitis using a JAK1 inhibitor.
    Type: Application
    Filed: April 28, 2022
    Publication date: September 1, 2022
    Applicant: AbbVie Inc.
    Inventors: Aileen L. Pangan, Roopal B. Thakkar, Steven Jungerwirth, Ana Paula Machado De Lacerda, Anne M. Robinson, Mohamed-Eslam F. Mohamed, Ahmed A. Othman, Ben Klünder
  • METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS
    Publication number: 20220259301
    Abstract: The present disclosure relates to methods of treating Crohn's disease or inducing remission of Crohn's disease in a subject. The present disclosure also relates to methods of treating ulcerative colitis or inducing remission of ulcerative colitis in a subject.
    Type: Application
    Filed: January 6, 2022
    Publication date: August 18, 2022
    Inventors: Kori Wallace, Anne M. Robinson, Ezequiel Neimark, Alexandra P. Song, Jasmina Kalabic, Bidan Huang, Xiaomei Liao, Graham A. Heap
  • METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS
    Publication number: 20190046527
    Abstract: The present disclosure is directed to methods for treating Crohn's disease, and in particular, to methods for inducing clinical remission and/or endoscopic improvement of Crohn's disease, using a JAK1 inhibitor. In certain embodiments, the patient is administered an induction dose of the JAK1 inhibitor to induce clinical remission and/or endoscopic improvement of the Crohn's disease, followed by administration of at least one maintenance dose of the JAK1 inhibitor thereafter. In other embodiments, the present disclosure is directed to methods for treating ulcerative colitis using a JAK1 inhibitor.
    Type: Application
    Filed: March 9, 2018
    Publication date: February 14, 2019
    Inventors: Roopal B. THAKKAR, Steven JUNGERWIRTH, Ana Paula Machado de LACERDA, Anne M. ROBINSON, Jose Jeffrey V. ENEJOSA, Aileen L. PANGAN, Mohamed-Eslam F. MOHAMED, Ahmed A. OTHMAN, Ben KLÜNDER